ACCENTURE/JSR/NTT
Accenture (NYSE: ACN), JSR Corporation, a chemicals manufacturer headquartered in Japan, and Nippon Telegraph and Telephone Corporation (NTT), one of the world's largest telecommunications services providers headquartered in Japan are embarking on a proof-of-concept project at JSR’s plant in Chiba Prefecture designed to improve worker productivity and safety in smart industrial complexes that is technology driven and analytics led.
The plan is to develop a ‘connected worker’ analytics platform leveraging smart sensors and wireless technology to automatically collect and analyze unstructured data – such as motion images and sound recordings from plant operation management and maintenance tasks performed by experienced workers at the Chiba Plant. The cross-company teams will work together to combine these insights with machine data from distributed control systems, and to develop a solution that will help users make more informed decisions using a machine learning algorithm in real-time. The goal is to convert the tacit knowledge of experienced workers into explicit knowledge, and transfer it to less experienced workers.
The proof-of-concept will integrate JSR’s insights in operation management and maintenance tasks, artificial intelligence “corevo®”(*) of NTT Group including NTT Advanced Technology Corporation, along with industry-leading digital transformation expertise and Industrial Internet of Things (IIoT) capabilities of Accenture Strategy . This proof-of-concept is based on the ideas of open innovation which is vital for a smart industrial complex, and one that integrates key capabilities from the three companies into one seamless digital transformation plan.
A smart industrial complex has the potential to improve knowledge transfer and address safety issues. This is a major priority for the Ministry of Economy, Trade and Industry, which recently announced a new Japanese industry plant safety policy, the Super Certified Plant System. The industry needs to address safety issues and establish stable, continuous operation, but faces additional challenges: a shrinking talent pool of experienced workers due to an aging workforce and investment spending constraints for IT solutions as spending has been required in recent years for safety solutions such as explosion prevention.
“The chemicals industry will face major transformation when digitalization makes it possible to detect signs of equipment abnormalities and predict product supply and demand,” said Mitsunobu Koshiba, representative director and president, JSR. “Harnessing the innovation of NTT and Accenture, we will promote a smart industrial complex and contribute to enhancing the competitive edge of Japan’s chemicals industry.”
“We are accelerating NTT’s transition to its new business model, B2B2X, and are committed to offering value-added services by collaborating with companies in different fields to extend our offerings,” said Jun Sawada, senior executive vice president, NTT. “This initiative helps establish a smart industrial complex and future growth of the chemicals industry in Japan, and it also embodies a business model for NTT that maximizes the potential of ICT.”
Connected worker technology is one element of what Accenture refers to as Industry X.0 - the digital reinvention of industry. It is when businesses use advanced digital technologies to transform their core operations, their worker and customer experiences and ultimately their business models.
“Digital disruption presents unparalleled growth and new value creation opportunities for Japan’s chemicals industry, especially when viewed through the Industry X.0 prism,” said Atsushi Egawa, representative director and president of Accenture Japan. “The deep chemicals industry expertise, and digital transformation and IIoT capabilities Accenture Strategy brings to the PoC will help embrace digital disruption in addition to improving plant productivity and worker safety. Turning this solution into a practical technology driven and analytics led business model will help us showcase that Industry X.0 can deliver new levels of efficiency in R&D, engineering, production, manufacturing and business support through integrated systems, processes, sensors and new intelligence.”
About JSR Corporation
JSR Corporation (formerly 'Japan Synthetic Rubber Co., Ltd.') was established in 1957 for domestic production of synthetic rubbers. Since then, JSR has continuously expanded its business to emulsions and plastics, and from the late 1970s, expanded to other materials for the semiconductor, flat panel display, and optical materials fields by leveraging our proprietary polymer technologies. In addition to the Petrochemicals and Fine Chemicals fields, JSR works on the Life Sciences field as one of its new business pillars to expand its profits.
About Nippon Telegraph and Telephone Corporation
NTT Group delivers advanced technology and innovative solutions in networking, software communications, and cloud computing that help transform businesses, governments and societies around the world. NTT Group will deliver convenient, enriched and reliable services to support customers as a “Value Partner” that its customers will continue to select. Today, 88% of Fortune 100 companies rely on NTT Group as their business partner. NTT Group generates over $105 billion in annual revenues, has over 240 data centers and employs more than 275,000 professionals working in 88 countries and regions.
About Accenture
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions - underpinned by the world’s largest delivery network - Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With more than 411,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com .
Accenture Strategy operates at the intersection of business and technology. We bring together our capabilities in business, technology, operations and function strategy to help our clients envision and execute industry-specific strategies that support enterprise wide transformation. Our focus on issues related to digital disruption, competitiveness, global operating models, talent and leadership help drive both efficiencies and growth. For more information, follow @AccentureStrat or visit www.accenture.com/strategy .
View source version on businesswire.com: http://www.businesswire.com/news/home/20170927006485/en/
Contact:
JSR
Nobuhiko Kuwashima, + 81 3 6218 3517
jsr_koho@jsr.co.jp
or
Nippon
Telegraph and Telephone Corporation
Public Relations
ntt-cnr-ml@hco.ntt.co.jp
or
Accenture
Japan
Shigeo Masuda, + 81 45 330 7157
accenture.jp.media@accenture.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom